BioNTech SE (BNTX) Cash & Current Investments (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Cash & Current Investments data on file, last reported at $17.3 billion in Q4 2025.

• For the quarter ending Q4 2025, Cash & Current Investments fell 3.44% year-over-year to $17.3 billion; the trailing twelve-month figure through Dec 2025 stood at $17.3 billion (down 3.44% YoY), and the FY2025 full-year result was $16.8 billion, down 6.28% from the prior year.
• Cash & Current Investments rose to $17.3 billion in Q4 2025, from $17.0 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $18.6 billion in Q2 2024 to a low of $432.8 million in Q3 2021.
• A 5-year average of $11.4 billion and a median of $15.4 billion in 2025 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments retreated 15.45% in 2022 and soared 1191.77% in 2023, its largest moves.
• Tracing BNTX's Cash & Current Investments over 5 years: stood at $2.4 billion in 2021, then soared by 504.7% to $14.3 billion in 2022, then advanced by 24.09% to $17.8 billion in 2023, then increased by 0.73% to $17.9 billion in 2024, then decreased by 3.44% to $17.3 billion in 2025.
• Business Quant data shows BNTX's Cash & Current Investments at $17.3 billion in Q4 2025, $17.0 billion in Q3 2025, and $15.9 billion in Q2 2025.